AU Patent

AU2019385420A1 — N-acylated fatty amino acids to reduce absorption variability in cannabinoid based compositions

Assigned to Spoke Sciences Inc · Expires 2021-07-08 · 5y expired

What this patent protects

The current disclosure provides use of

USPTO Abstract

The current disclosure provides use of

Drugs covered by this patent

Patent Metadata

Patent number
AU2019385420A1
Jurisdiction
AU
Classification
—
Expires
2021-07-08
Drug substance claim
No
Drug product claim
No
Assignee
Spoke Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.